AQR Arbitrage’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-401,880
Closed -$4.12M – 938
2023
Q2
$4.12M Buy
401,880
+124,552
+45% +$1.27M 0.18% 151
2023
Q1
$2.81M Hold
277,328
– – 0.09% 267
2022
Q4
$2.75M Buy
277,328
+20,000
+8% +$197K 0.07% 348
2022
Q3
$2.49M Hold
257,328
– – 0.05% 435
2022
Q2
$2.49M Buy
+257,328
New +$2.5M 0.06% 404

AQR Arbitrage's DALS Position: Q3 2023 in Review

AQR Arbitrage sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 401,880 shares — an estimated $4.12M sold.

AQR Arbitrage first reported a position in DALS in Q2 2022 and held it in 5 quarters. The position peaked at $4.12M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • AQR Arbitrage reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • AQR Arbitrage sold 401,880 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $4.12M.
  • AQR Arbitrage first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2022 and held it in 5 quarters.
  • AQR Arbitrage's DA32 Life Science Tech Acquisition Corp position peaked at $4.12M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.